These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 32572773)

  • 1. Spatial-Cluster Signal Detection in Medical Devices Using Likelihood Ratio Test Method.
    Hu T; Huang L; Xu J; Tiwari R
    Ther Innov Regul Sci; 2021 Jan; 55(1):56-64. PubMed ID: 32572773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood Ratio Test Method for Multiple Medical Devices Comparison Using Multiple-Site Data with Continuous Outcomes.
    Hu T; Xu J; Huang L; Xu Z; Yao Z; Tiwari R
    Ther Innov Regul Sci; 2020 Nov; 54(6):1444-1452. PubMed ID: 32529632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating medical device adverse event signals using a likelihood ratio test method.
    Xu Z; Xu J; Yao Z; Huang L; Jung M; Tiwari R
    J Biopharm Stat; 2021 Jan; 31(1):37-46. PubMed ID: 32594849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Likelihood-Ratio-Test Methods for Drug Safety Signal Detection from Multiple Clinical Datasets.
    Huang L; Zalkikar J; Tiwari R
    Comput Math Methods Med; 2019; 2019():1526290. PubMed ID: 30915153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zero-inflated Poisson model based likelihood ratio test for drug safety signal detection.
    Huang L; Zheng D; Zalkikar J; Tiwari R
    Stat Methods Med Res; 2017 Feb; 26(1):471-488. PubMed ID: 25189699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
    Huang L; Zalkikar J; Tiwari RC
    J Biopharm Stat; 2013; 23(1):178-200. PubMed ID: 23331230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended likelihood ratio test-based methods for signal detection in a drug class with application to FDA's adverse event reporting system database.
    Zhao Y; Yi M; Tiwari RC
    Stat Methods Med Res; 2018 Mar; 27(3):876-890. PubMed ID: 27142982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial cluster detection for ordinal outcome data.
    Jung I; Lee H
    Stat Med; 2012 Dec; 31(29):4040-8. PubMed ID: 22807106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using simulation to assess the sensitivity and specificity of a signal detection tool for multidimensional public health surveillance data.
    Rolka H; Bracy D; Russell C; Fram D; Ball R
    Stat Med; 2005 Feb; 24(4):551-62. PubMed ID: 15678409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear trend tests for case-control genetic association that incorporate random phenotype and genotype misclassification error.
    Gordon D; Haynes C; Yang Y; Kramer PL; Finch SJ
    Genet Epidemiol; 2007 Dec; 31(8):853-70. PubMed ID: 17565750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
    Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
    Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical device active surveillance of spontaneous reports: A literature review of signal detection methods.
    Chung G; Etter K; Yoo A
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):369-379. PubMed ID: 32128936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.
    Nomura K; Takahashi K; Hinomura Y; Kawaguchi G; Matsushita Y; Marui H; Anzai T; Hashiguchi M; Mochizuki M
    Drug Des Devel Ther; 2015; 9():3031-41. PubMed ID: 26109846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005-2016.
    Kim KS; Oh IS; Kim HJ; Song I; Park MS; Shin JY
    Yonsei Med J; 2020 Mar; 61(3):243-250. PubMed ID: 32102125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simulation study for geographic cluster detection analysis on population-based health survey data using spatial scan statistics.
    Moon J; Jung I
    Int J Health Geogr; 2022 Sep; 21(1):11. PubMed ID: 36085072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators.
    Bates J; Parzynski CS; Dhruva SS; Coppi A; Kuntz R; Li SX; Marinac-Dabic D; Masoudi FA; Shaw RE; Warner F; Krumholz HM; Ross JS
    Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):848-856. PubMed ID: 29896873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood ratio based tests for longitudinal drug safety data.
    Huang L; Zalkikar J; Tiwari R
    Stat Med; 2014 Jun; 33(14):2408-24. PubMed ID: 24919793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal detection in FDA AERS database using Dirichlet process.
    Hu N; Huang L; Tiwari RC
    Stat Med; 2015 Aug; 34(19):2725-42. PubMed ID: 25924820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
    Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
    JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.